Ownership history in MARSHALL WACE, LLP Β· 12 quarters on record
This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in CODEXIS INC (CDXS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π MARSHALL WACE, LLP underperformed the S&P 500 by β89.1% annually on this CDXS position. Timing score: 40% (4/10 decisions correct). Average cost basis: $23.48. Maximum drawdown during holding period: β92.2%.
β Significantly underperformed the S&P 500 by 89.1% ann.
10 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
4 of 10 add/trim decisions correct
Best entry: $2.44 (2025 Q2) Β· Worst: $31.27 (2021 Q4)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
8 adds Β· 4 trims. Bought during 4 of 6 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size